Galapagos NV
GLPG
#5040
Rank
HK$14.61 B
Marketcap
HK$217.58
Share price
0.00%
Change (1 day)
-16.04%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -HK$3.06

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$3.20. In 2025 the company made an earnings per share (EPS) of HK$44.89 an increase over its 2024 EPS that were of HK$9.14.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$3.06-106.82%
2025HK$44.89390.86%
2024HK$9.14-67.16%
2023HK$27.84-199.64%
2022-HK$27.9499.03%
2021-HK$14.04-68.98%
2020-HK$45.26-298.06%
2019HK$22.85-554.64%
2018-HK$5.03-77.18%
2017-HK$22.03-326.21%
2016HK$9.74-134.19%
2015-HK$28.48-371.34%
2014HK$10.50-445.98%
2013-HK$3.0332.88%
2012-HK$2.28-82.07%
2011-HK$12.74-817.9%
2010HK$1.7712.73%
2009HK$1.57-120.79%
2008-HK$7.57-37.67%
2007-HK$12.1439.64%
2006-HK$8.7028.17%
2005-HK$6.796.25%
2004-HK$6.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.53-2,243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$24.47-865.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$28.01-976.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.93-567.13%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$9.93-410.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.41-1,739.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$25.09-884.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
HK$31.31-1,079.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94-254.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel